Sabine Oertelt-Prigione MD, PhD, MScPH has been working in the field of sex and gender-sensitive research for the last 15 years. After her medical studies, she investigated the biological basis of sex differences in autoimmunity. She then focused on the role of sex and gender in cardiovascular diseases. Realizing that the implementation of sex and gender-sensitive medicine is a change process that affects organizations as much as researchers, she obtained training as an organizational consultant. With these tools she is now trying to understand how sex and gender-sensitive medicine can be successfully implemented. Her work focuses on the entire implementation arch: What is the status quo in sex and gender-sensitive research? What should be done? What is practically feasible in an everyday clinical and research context? And, finally, how to we institutionalize these practices? She has developed the first international database about sex and gender-specific research, co-editor of one of the first textbooks in the discipline and has conducted the largest study in Europe on gendered harassment in academia. She worked with the EU Commission in the EU expert group “Gendered Innovations”, consults with national governments and funding agencies and advises startups that want to focus on sex and gender-sensitive topics.

Professor Matej Orešič holds a PhD in biophysics from Cornell University (1999; Ithaca, NY, USA). He is a Professor of Medical Sciences at Örebro University (Sweden), group leader in systems medicine at the University of Turku (Finland), and a guest professor in lipids and nutrition at the Oil Crops Research Institute in Wuhan (China). As of 2016, he was made a Lifetime Honorary Fellow of the Metabolomics Society. He previously served as member of the Board of Directors of the Metabolomics Society for two, consecutive terms (2008-2012). Prof. Orešič is one of the founders of the Nordic Metabolomics Society and currently its chair of the board. In 2019, he co-chaired the 1st Gordon Research Conference on ‘Metabolomics and Human Health’ (Ventura, CA, USA). Previously, he also chaired the Keystone Symposium on Systems Biology of Lipid Metabolism (2015; Breckenridge, CO, USA). Prof. Orešič’s main research areas include metabolomics applications in biomedical research and systems medicine. He is particularly interested in the identification of disease processes associated with different metabolic phenotypes and the underlying mechanisms linking these processes with the development of specific disorders or their co-morbidities, with a central focus on both type 1 diabetes and non-alcoholic fatty liver disease. Prof. Orešič also initiated the popular MZmine open source project, which led to the development and release of popular software for metabolomics data processing.